The Brigham and Dana-Farber Board Review in Hematology and Oncology 2020

$35

59Video Files (.mp4 format) + 1 PDF File.
File Size = 7.44 GB

Course Introduction: The Brigham and Dana-Farber Board Review in Hematology and Oncology 2020 Download Link

Format:

59Video Files (.mp4 format) + 1 PDF File.
File Size = 7.44 GB

Overview – Topics/Speakers:

Improve Patient Care in Hematology and Oncology

The Brigham and Dana-Farber Board Review in Hematology and Oncology will help improve clinical practice gaps in hematology and oncology derived from the American Board of Internal Medicine (ABIM) certification/recertification requirements. In this CME program, expert speakers address relevant topics in case-based board review presentations. Improve patient care by learning to:

  • Perform differential diagnosis of complex hematologic and oncologic disorders
  • Identify and apply current therapeutic options for hematologic and oncologic disorders
  • Evaluate and interpret up-to-date literature relevant to hematology and oncology
  • Illustrate knowledge of pathophysiology of hematologic and oncologic disorders
  • Apply new knowledge to the ABIM certification/recertification hematology and oncology examinations

Discover New Guidelines

This learn-at-your-own-pace course in hematology and oncology provides a maximum of 44 AMA PRA Category 1 Credits ™ and 44 ABIM MOC points. Available online or via audio MP3 CDs, it provides access to unbiased, evidence-based content and case-based reviews so you can expand your knowledge and incorporate the latest guidelines into your daily practice

 

TOPICS/SPEAKERS

  • Molecular Genetics of Cancer – Nikhil Wagle, MD
  • Advances in Cancer Drug Development – Geoffrey I. Shapiro, MD, PhD
  • Infections in Cancer Patients – Lindsey Baden, MD
  • Symptom Management in Patients with Cancer – Andrew J. Lawton, MD
  • Communication: The Key to Excellence in End-of-Life Care – Rachelle E. Bernacki, MD
  • Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD
  • Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD
  • Acute Leukemias – Daniel J. DeAngelo, MD, PhD
  • Myelodysplastic Syndrome – David P. Steensma, MD
  • Chronic Myelogenous Leukemia – Marlise R. Luskin, MD
  • Myeloproliferative Syndromes – Ann M. Mullally, MD
  • Multiple Myeloma – Kenneth C. Anderson, MD
  • Waldenstrom Macroglobulemia and Amyloidosis – Jorge J. Castillo, MD
  • Low Grade Lymphomas – Caron A. Jacobson, MD
  • High Grade Lymphomas – Eric D. Jacobsen, MD
  • Hodgkin’s Lymphoma – Jennifer L. Crombie, MD
  • Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD
  • Head and Neck Cancer – Robert I. Haddad, MD
  • Natural History, Screening, Surgery and Small Cell Lung Cancer – Bruce E. Johnson, MD
  • Non Small Cell Lung Cancer – Mark Awad, MD, PhD
  • Mesothelioma and Thymoma – David M. Jackman, MD
  • Thyroid Cancer – Jochen Lorch, MD
  • Carcinoid and Pancreatic Neuroendocrine Tumors – Jennifer Ang Chan, MD
  • Esophageal and Gastric Cancer – Peter C. Enzinger, MD
  • Pancreatic and Hepatobiliary Cancer – Brian M. Wolpin, MD
  • Anal Cancers – Robert J. Mayer, MD
  • Colorectal Cancers – Robert J. Mayer, MD
  • Gastrointestinal Cancer: Genetic Syndromes – Matthew Yurgelun, MD
  • Germ Cell Tumor: Maximizing Cure While Minimizing the Burden of Therapy – Mark M. Pomerantz, MD
  • Renal and Bladder Cancer – Guru P. Sonpavde, MBBS
  • Prostate Cancer Part I: Overview and Management of Localized Disease – Atish D. Choudhury, MD, PhD
  • Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish D. Choudhury, MD, PhD
  • Melanoma – F. Stephen Hodi, MD
  • Sarcomas and Gastrointestinal Stromal Tumors (GIST) – George D. Demetri, MD
  • Ovarian Cancer – Ursula A. Matulonis, MD
  • Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD
  • Neuro-oncology – David A. Reardon, MD
  • Breast Cancer: Risk Factors, Genetics, Screening, and Prevention – Judy E. Garber, MD, MPH
  • Multimodality Therapy for Early Stage Breast Cancer: Part 1 – Surgery and Radiation – Harold J. Burstein, MD, PhD
  • Multimodality Therapy for Early Stage Breast Cancer: Part 2 – Systemic Therapy – Harold J. Burstein, MD, PhD
  • Management of Metastatic Breast Cancer – Erica Mayer, MD, MPH
  • Breast Cancer Survivorship – Ann H. Partridge, MD, MPH
  • Hematopoiesis and Cytokines – David T. Scadden, MD
  • Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD
  • Congenital Bone Marrow Failure – Akiko Shimamura, MD, PhD
  • Hemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD
  • Anemia: An Overview – Ronald P. McCaffrey, MD
  • Iron Deficiency and Iron Overload – Mark D. Fleming, MD, PhD
  • Immune Hemolytic Anemia – Richard M. Kaufman, MD
  • Non-immune Hemolytic Anemia – David E. Golan, PhD, MD
  • Sickle Cell Disease – Maureen M. Achebe, MD, MPH
  • Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD
  • Disorders of Neutrophils – Nancy Berliner, MD
  • Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD
  • Hemophilia – Aric D. Parnes, MD
  • Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH
  • Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD
  • Use of Direct Oral Anticoagulants in Clinical Practice – Jean M. Connors, MD
  • Transfusion Medicine for the Clinician – Walter H. Dzik, MD

Date of Original Release: April 15, 2020
Termination Date: April 15, 2023

Delivery Method

you will receive download link of the course, the link will NOT expire and can be used anytime

 

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Shopping Cart
Scroll to Top
Scroll to Top